Research Article

Related GMR Articles

11/19/2015
Osteosarcoma; Polymorphism; Vascular endothelial growth factor

We conducted a case-control study to assess the role of vascular endothelial growth factor (VEGF) -634G/C, +936C/T, and +1612G/A genetic variations in the development of osteosarcoma in a Chinese population. This hospital-based case-control study examined 130 patients with osteosarcoma and 130 age- and gender-matched healthy controls from March 2011 and March 2013. Polymerase ... more

G.L. Hu; G. Ma; J.H. Ming
11/13/2015
Invasion; miR-184; Osteosarcoma; Proliferation

Osteosarcoma is a highly malignant cancer that often appears in teenagers. It is the most frequently occurring primary bone tumor, and can easily metastasize, resulting in high mortality. MicroRNAs express abnormally in osteosarcoma, and may function as oncogenes or tumor suppressors. Recent studies showed that microRNA184 (miR-184) is abnormally expressed in multiple tumors, and is ... more

G.R. Yin; Q. Wang; X.B. Zhang; S.J. Wang
10/02/2015
Cytotoxic T lymphocytes; Dendritic cells; Immunotherapy; Osteosarcoma

The aim of this study was to investigate the effects of dendritic cell (DC) therapy in osteosarcoma. Bone marrow DCs from Wistar (allograft group) and Sprague Dawley (SD) (homograft group) rats were electrically fused with the SD-derived osteosarcoma cell line UMR106 to generate a DC-osteosarcoma fusion (DOF) tumor vaccine, which was co-incubated with SD T lymphocytes to stimulate T cell ... more

X. Fang; C. Jiang; Q. Xia
03/28/2016
Apoptosis; Invasion; MicroRNA-9; Migration; Osteosarcoma; Proliferation

MicroRNA-9 (miR-9) has a well-established role in various tumors; the clinical significance and potential mechanism of miR-9 in human osteosarcoma (OS) has not been elucidated. The aim of this study was to investigate the mechanism and role of miR-9 expression in osteosarcoma cells. miR-9 expression in the OS cell line MG-63 and OS tissues was compared to that in a human osteoblastic cell ... more

X.J. Qi; J.F. Wang; G.D. Wang; Q. Xu; H.L. Sun; X.J. Qi; J.F. Wang; G.D. Wang; Q. Xu; H.L. Sun; X.J. Qi; J.F. Wang; G.D. Wang; Q. Xu; H.L. Sun
03/28/2016
BANCR; Invasion; Long noncoding RNA; Osteosarcoma; Prognosis
Z.Q. Peng; R.B. Lu; D.M. Xiao; Z.M. Xiao; Z.Q. Peng; R.B. Lu; D.M. Xiao; Z.M. Xiao
12/19/2016
Adult; Aged; Apoptosis; Bone neoplasms; Caspase 8; Cell proliferation; Cell survival; Female; Gene Expression Regulation, Neoplastic; Humans; male; Middle Aged; Osteochondroma; Osteosarcoma; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Young Adult

Osteosarcoma is a common malignant bone tumor that mainly affects children and adolescents. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor superfamily. Caspase-8 appears in the upstream of apoptosis signaling pathway among caspases. We investigated TRAIL and caspase-8 levels in osteosarcoma patients to determine their correlation with ... more

X. Ning; X.W. Shang; Y. Zhuang; M. Liu; H. Yang; H. Zhang; M.Z. Huang
09/22/2015
Chemotherapy; Clinical outcome; Glutathione S-transferases; Polymorphism

The aim of this study was to evaluate the role of GSTM1 null/present, GSTT1 null/present, and GSTP1 IIe105Val polymor­phisms in the clinical response to chemotherapy and treatment outcome of patients with breast cancer. A total of 262 subjects were randomly selected from among patients with a histologically confirmed breast cancer. The genotypes of GSTM1, ... more

J. Wang; T. Wang; G.Y. Yin; L. Yang; Z.G. Wang; X.B. Bu
12/28/2015
Acute leukemia; Chemotherapy; DR5; TRAIL

We investigated the roles of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor death receptor 5 (DR5) in the onset of acute leukemia and changes in their expression during chemotherapy. Bone marrow samples from 16 patients newly diagnosed with acute leukemia were collected before chemotherapy. Bone marrow samples from patients with non-hematologic ... more

S.M. Chen; H. Sun; Y.F. Liu; J. Ma; Q.T. Zhang; J. Zhu; T. Li
12/11/2015
Breast cancer; Chemotherapy; Glutathione S-transferases; Polymorphism

The aim of this study was to evaluate the role of GSTM1 null/present, GSTT1 null/present, and GSTP1 polymorphisms in the clinical response to chemotherapy and treatment outcome of breast cancer. The GSTM1, GSTT1, and GSTP1 IIe105Val polymorphism genotypes were analyzed using polymerase chain reaction coupled with restriction fragment ... more

P. Yuan; L. Yuan; B.L. Xu; C.Z. Wang; H.Z. Yang; Y. Li
10/05/2015
Adjuvant treatment; Chemotherapy; Interferon-α-2b; Oral mucosal melanoma; Survival

Two major subtypes of melanoma include cutaneous melanoma and mucosal melanoma. The latter type is rare and usually occurs in the head and neck region. High-dose interferon-α-2b (IFN-α-2b) has proven effective in the treatment of cutaneous melanoma. Recently, a regimen of temozolomide plus cisplatin was reported more likely to improve relapse-free survival and overall survival than high- ... more

R. Wang; G. Jing; J. Lv; H. Song; C. Li; X. Wang; W. Xia; Y. Wu; G. Ren; W. Guo

Pages